RARE•globenewswire•
Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference
Summary
NOVATO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's chief executive officer and president, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 7, 2026 by globenewswire